MedPath

Radboud University Medical Center

Radboud University Medical Center logo
🇳🇱Netherlands
Ownership
Private
Established
1951-01-01
Employees
-
Market Cap
-
Website
http://www.radboudumc.nl

Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy

Phase 2
Completed
Conditions
Locally Advanced Non-Small Cell Lung Cancer
NSCLC
First Posted Date
2008-06-20
Last Posted Date
2013-07-15
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
35
Registration Number
NCT00702975
Locations
🇳🇱

University Lung Centre Nijmegen Dekkerswald, Groesbeek, Gelderland, Netherlands

Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction

Phase 2
Completed
Conditions
Type 2 Diabetes Mellitus Related Endothelial Dysfunction
Interventions
First Posted Date
2008-06-13
Last Posted Date
2010-01-26
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
16
Registration Number
NCT00696722
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy

Phase 2
Completed
Conditions
Idiopathic Membranous Nephropathy
Interventions
First Posted Date
2008-06-11
Last Posted Date
2013-01-07
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
20
Registration Number
NCT00694863
Locations
🇳🇱

Radboud University, Nijmegen, Netherlands

Dynamic Computed Tomography Angiography (CTA) Follow-up for EndoVascular Aortic Replacement (EVAR)

Conditions
Aortic Aneurysm
First Posted Date
2008-05-19
Last Posted Date
2008-05-19
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
40
Registration Number
NCT00680004
Locations
🇳🇱

UMC St Radboud, Nijmegen, Netherlands

Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Phase 1
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2008-04-24
Last Posted Date
2020-11-12
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
12
Registration Number
NCT00665951
Locations
🇳🇱

Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands

The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)

Phase 1
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2008-04-24
Last Posted Date
2020-10-19
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
24
Registration Number
NCT00665717
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

PET/CT Imaging of Aneurysm Wall Inflammation

Conditions
Aortic Aneurysm
First Posted Date
2008-04-18
Last Posted Date
2008-04-18
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
35
Registration Number
NCT00661518
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Phase 2
Conditions
Colorectal Neoplasms
Liver Neoplasms
Interventions
Procedure: immediate surgery (resection of primary colorectal tumor)
Drug: neo-adjuvant treatment with bevacizumab
Drug: neoadjuvant treatment with capecitabine and oxaliplatin
Drug: neo-adjuvant treatment with bevacizumab, capecitabine and oxaliplatin
First Posted Date
2008-04-16
Last Posted Date
2011-09-12
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
60
Registration Number
NCT00659022
Locations
🇳🇱

Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

🇳🇱

The Netherlands Cancer Institute/ Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

Circulatory Changes During Venovenous (VV)- and Venoarterial (VA) Extracorporeal Membrane Oxygenation (ECMO)

Conditions
Pulmonary Hypertension of the Newborn (PPHN)
Interventions
Other: echocardiography Doppler sonography, blood and urine sampling
First Posted Date
2008-02-25
Last Posted Date
2008-02-25
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
30
Registration Number
NCT00622492
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

A Cluster Randomized Controlled Trial in Primary Oral Care

Early Phase 1
Completed
Conditions
Tooth, Impacted
Interventions
Behavioral: peer group educational implementation strategy
First Posted Date
2008-02-19
Last Posted Date
2008-02-19
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
1161
Registration Number
NCT00618215
Locations
🇳🇱

University Medical Centre St Radboud, Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath